The purchase agreement must be in writing to be legally binding | The Global Dispatch theglobaldispatch.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theglobaldispatch.com Daily Mail and Mail on Sunday newspapers.
While global health advocates applauded the Biden administration s recent decision to support waiving intellectual property protections for Covid-19 vaccines as critical, transformative, and unquestionably the right thing to do, Big Pharma took a decidedly less optimistic view of the move and has been hard at work behind the scenes in a bid to thwart the policy, a report published Friday by
The Intercept revealed.
In a bid to stymie U.S. support for a proposal by India and South Africa to enact a Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver at the World Trade Organization (WTO), the pharmaceutical industry is distributing talking points, organizing opposition, and even collecting congressional signatures in an attempt to reverse President Joe Biden s support for worldwide access to generic Covid-19 vaccines, according to
Patents are a necessary evil. The problem is that the degrees both of necessity and of evil vary greatly from product to product. Yet simplicity demands that there be one common protective term for all new patents.
That is the core issue of whether patent rights on COVID-19 vaccines should be âwaivedâ internationally to diversify and speed their production for billions of people yet unvaccinated, especially in catastrophically smitten countries such as India and Brazil.
The necessity is that we not only need new drugs, but we need technological innovation generally. The evil is that patents create monopoly power. History and economics both prove that monopoly power fosters abuse, often flagrant, of the public and transfers wealth from poorer people to richer.
Biden call fuels vaccine effort for poor nations May 14, 2021
After U.S. President Joe Biden’s surprise turnaround in favour of temporarily suspending patent protection for COVID-19 vaccines, Church leaders are redoubling their lobbying, hoping a World Trade Organization agreement will get vaccines into arms south of the equator.
Meanwhile Canada refuses to say whether it will support the new U.S. position at the next WTO meetings June 8-9.
At previous WTO meetings to discuss the issue, Canada asked a series of wide-ranging questions about how the TRIPS waiver would speed up vaccine production and distribution. The questions prevented the proposal from moving forward.
COVID IP Waiver Doesn t Resolve Vaccine Production Barriers By
William Bergmann Law360 is providing free access to its coronavirus coverage to make sure all members of the legal community have accurate information in this time of uncertainty and change. Use the form below to sign up for any of our weekly newsletters. Signing up for any of our section newsletters will opt you in to the weekly Coronavirus briefing.
Sign up for our Environmental newsletter
You must correct or enter the following before you can sign up:
Email (NOTE: Free email domains not supported)
Primary area of interest Law360 (May 13, 2021, 4:44 PM EDT)